Antitumoral activity of a CDK12 inhibitor in colorectal cancer through a liposomal formulation
Author:
Funder
ISCIII
CRIS Cancer Foundation
Publisher
Elsevier BV
Reference38 articles.
1. Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options;Ocaña;Clin. Cancer Res.,2008
2. Efficacy, safety, tolerability and price of newly approved drugs in solid tumors;Barnes;Cancer Treat. Rev.,2017
3. The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment;Morrison;Nat. Rev. Clin. Oncol.,2024
4. Cyclin-dependent kinases: a family portrait;Malumbres;Nat. Cell Biol.,2009
5. Cdk12 is a gene-selective RNA polymerase II kinase that regulates a subset of the transcriptome, including Nrf2 target genes;Li;Sci. Rep.,2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3